JPWO2020239953A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020239953A5
JPWO2020239953A5 JP2021571021A JP2021571021A JPWO2020239953A5 JP WO2020239953 A5 JPWO2020239953 A5 JP WO2020239953A5 JP 2021571021 A JP2021571021 A JP 2021571021A JP 2021571021 A JP2021571021 A JP 2021571021A JP WO2020239953 A5 JPWO2020239953 A5 JP WO2020239953A5
Authority
JP
Japan
Prior art keywords
pyrido
pyrimidin
amine
methyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021571021A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534434A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/064915 external-priority patent/WO2020239953A1/en
Publication of JP2022534434A publication Critical patent/JP2022534434A/ja
Publication of JPWO2020239953A5 publication Critical patent/JPWO2020239953A5/ja
Pending legal-status Critical Current

Links

JP2021571021A 2019-05-31 2020-05-28 P2x3阻害剤としてのピリドピリミジン誘導体 Pending JP2022534434A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19177610.3 2019-05-31
EP19177610 2019-05-31
EP19201165.8 2019-10-02
EP19201165 2019-10-02
PCT/EP2020/064915 WO2020239953A1 (en) 2019-05-31 2020-05-28 Pyridopyrimidines derivatives as p2x3 inhibitors

Publications (2)

Publication Number Publication Date
JP2022534434A JP2022534434A (ja) 2022-07-29
JPWO2020239953A5 true JPWO2020239953A5 (US06244707-20010612-C00010.png) 2023-06-06

Family

ID=70857198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021571021A Pending JP2022534434A (ja) 2019-05-31 2020-05-28 P2x3阻害剤としてのピリドピリミジン誘導体

Country Status (11)

Country Link
US (1) US20230212169A9 (US06244707-20010612-C00010.png)
EP (1) EP3976609A1 (US06244707-20010612-C00010.png)
JP (1) JP2022534434A (US06244707-20010612-C00010.png)
KR (1) KR20220016074A (US06244707-20010612-C00010.png)
CN (1) CN114222741A (US06244707-20010612-C00010.png)
AU (1) AU2020281924A1 (US06244707-20010612-C00010.png)
BR (1) BR112021020279A2 (US06244707-20010612-C00010.png)
CA (1) CA3136024A1 (US06244707-20010612-C00010.png)
MA (1) MA56020A (US06244707-20010612-C00010.png)
MX (1) MX2021014116A (US06244707-20010612-C00010.png)
WO (1) WO2020239953A1 (US06244707-20010612-C00010.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022160931A1 (zh) * 2021-01-28 2022-08-04 浙江海正药业股份有限公司 吡啶并嘧啶类衍生物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4342007B2 (ja) * 1998-08-10 2009-10-14 大日本住友製薬株式会社 キナゾリン誘導体
MX2008002733A (es) * 2005-09-01 2008-03-26 Hoffmann La Roche Diaminopirimidinas como moduladores p2x3 y p2x2/3.
WO2008000645A1 (en) 2006-06-29 2008-01-03 F. Hoffmann-La Roche Ag Tetrazole-substituted arylamides
WO2008123963A1 (en) * 2007-04-02 2008-10-16 Renovis, Inc. Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
JP5498374B2 (ja) 2007-04-17 2014-05-21 エボテック・アーゲー 2−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用
MX2010009561A (es) 2008-02-29 2010-09-24 Renovis Inc Compuestos amida, composiciones y usos de los mismos.
EP2346825A2 (en) 2008-09-18 2011-07-27 Evotec AG Modulators of p2x3 receptor activity
WO2011041655A1 (en) * 2009-10-01 2011-04-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Quinazolin-4-amine derivatives; and methods of use
CA2817577A1 (en) * 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2016084922A1 (ja) 2014-11-28 2016-06-02 塩野義製薬株式会社 1,2,4-トリアジン誘導体およびその医薬組成物
JPWO2016088838A1 (ja) 2014-12-04 2017-09-14 塩野義製薬株式会社 プリン誘導体およびその医薬組成物
EP3230281B1 (en) 2014-12-09 2021-05-26 Bayer Aktiengesellschaft 1,3-thiazol-2-yl substituted benzamides
WO2017011729A1 (en) 2015-07-16 2017-01-19 Patara Pharma, LLC Combination therapies for the treatment of lung diseases
DK3355889T3 (da) 2015-09-29 2023-05-15 Afferent Pharmaceuticals Inc Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste
CN109641886B (zh) * 2015-11-25 2022-11-18 康威基内有限公司 双环bet布罗莫结构域抑制剂及其用途
GB201700814D0 (en) * 2017-01-17 2017-03-01 Liverpool School Tropical Medicine Compounds
JP7093462B2 (ja) * 2018-07-25 2022-06-29 ファエス・ファルマ・ソシエダッド・アノニマ ヒスタミンh4受容体阻害剤としてのピリドピリミジン

Similar Documents

Publication Publication Date Title
HRP20171913T1 (hr) Aminopirimidinilni spojevi kao inhibitori jak
JP2017512786A5 (US06244707-20010612-C00010.png)
RU2417994C2 (ru) Производные пиразина, полезные в качестве антагонистов аденозинового рецептора
AU2012299080B2 (en) Pyrimidine PDE10 inhibitors
JP2019504009A5 (US06244707-20010612-C00010.png)
JP2021502356A5 (US06244707-20010612-C00010.png)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2017508766A5 (US06244707-20010612-C00010.png)
JP2018503673A5 (US06244707-20010612-C00010.png)
JP2012525395A5 (US06244707-20010612-C00010.png)
JP2016522246A5 (US06244707-20010612-C00010.png)
JP2017512794A5 (US06244707-20010612-C00010.png)
JP2019535728A (ja) キナーゼ阻害剤としての複素環式アミド
JP2015514794A5 (US06244707-20010612-C00010.png)
RU2016141647A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
JP2010513444A5 (US06244707-20010612-C00010.png)
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
JP2007510689A5 (US06244707-20010612-C00010.png)
JP2010512337A5 (US06244707-20010612-C00010.png)
JP2008509955A5 (US06244707-20010612-C00010.png)
JP2017537948A5 (US06244707-20010612-C00010.png)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
JP2017523223A5 (US06244707-20010612-C00010.png)
RU2013145299A (ru) Тиазолопиримидины
JP2019505595A5 (US06244707-20010612-C00010.png)